Pyrotech Therapeutics, Inc.
Clinical trials sponsored by Pyrotech Therapeutics, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New investigational drug PTT-121: a first step toward future therapies? Results expected Aug 2027 (estimated)
-
Can a new pill tame ulcerative colitis when others fail?
Disease control Not yet recruitingThis trial is testing an experimental oral drug called PTT-621 in adults aged 18-70 with moderate-to-severe ulcerative colitis who haven't responded well to standard treatments. Participants will take PTT-621 tablets for 12 weeks. The main goal is to see if the drug can improve t…
Phase 2 • Sponsor: Pyrotech Therapeutics, Inc. • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New investigational drug PTT-121: a first step toward future therapies?
Knowledge-focused Not yet recruitingThis early-stage trial is testing an investigational drug called PTT-121 in healthy Chinese adults. The main goal is to see if the drug is safe and tolerable when given intravenously, and to understand how the body processes it. Participants will receive either the drug or a plac…
Phase 1 • Sponsor: Pyrotech Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC